| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | LION BIOTECHNOLOGIES INC COM | 499,815 | 3,859,000 | 0.46% | ||
| 52 | IMMUNE DESIGN CORP | 189,000 | 3,795,000 | 0.45% | ||
| 53 | ZYNERBA PHARMACEUTICALS INC | 356,600 | 3,591,000 | 0.43% | ||
| 54 | Curis, Inc | 1,162,400 | 3,383,000 | 0.40% | ||
| 55 | EPIRUS BIOPHARMA | 896,600 | 2,770,000 | 0.33% | ||
| 56 | APTOSE BIOSCIENCES INC | 1,081,867 | 2,737,000 | 0.33% | ||
| 57 | BLUEPRINT MEDICINES CORP COM | 100,000 | 2,634,000 | 0.32% | ||
| 58 | REGENXBIO INC COM | 156,741 | 2,602,000 | 0.31% | ||
| 59 | OVASCIENCE INC COM | 252,180 | 2,464,000 | 0.29% | ||
| 60 | GENVEC INC | 1,176,235 | 2,164,000 | 0.26% | ||
| 61 | TETRALOGIC PHARMACEUTICALS C | 5,000,000 | 2,078,000 | 0.25% | ||
| 62 | AQUINOX PHARMACEUTICALS INC | 150,000 | 1,872,000 | 0.22% | ||
| 63 | Agile Therapeutics, Inc. | 182,053 | 1,777,000 | 0.21% | ||
| 64 | GLYCOMIMETICS INC | 283,555 | 1,622,000 | 0.19% | ||
| 65 | AMICUS THERAPEUTICS INC COM | 150,000 | 1,455,000 | 0.17% | ||
| 66 | AVEO PHARMACEUTICALS INC | 1,087,715 | 1,371,000 | 0.16% | ||
| 67 | Ascendis Pharma | 61,500 | 1,127,000 | 0.13% | ||
| 68 | CONTRAFECT CORP COM | 234,406 | 1,113,000 | 0.13% | ||
| 69 | VERACYTE INC | 137,990 | 994,000 | 0.12% | ||
| 70 | HTG Molecular Diagnostics Inc | 201,000 | 876,000 | 0.10% | ||
| 71 | PROVECTUS | 2,200,000 | 858,000 | 0.10% | ||
| 72 | Sierra Oncology, Inc. | 53,153 | 799,000 | 0.10% | ||
| 73 | Biotie Therapies Corp. | 50,000 | 718,000 | 0.09% | ||
| 74 | NEOS THERAPEUTICS INC COM | 50,000 | 716,000 | 0.09% | ||
| 75 | NANOSTRING TECHNOLOGIES INC | 40,000 | 588,000 | 0.07% | ||
| 76 | PROVECTUS BIOPHARMACEUTICALS | 2,200,000 | 550,000 | 0.07% | ||
| 77 | THRESHOLD PHARMACEUTICAL INC | 1,000,000 | 480,000 | 0.06% | ||
| 78 | Cellectar Biosciences @4.68 8/ | 530,000 | 390,000 | 0.05% | ||
| 79 | APPLIED GENETIC TECHNOL CORP | 17,110 | 349,000 | 0.04% | ||
| 80 | ADAPTIMMUNE THERAPEUTICS PLC | 25,000 | 302,000 | 0.04% | ||
| 81 | CELLECTAR BIOSCIENCES INC | 530,000 | 296,000 | 0.04% | ||
| 82 | REGULUS THERAPEUTICS INC COM | 30,656 | 267,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-053224, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
